Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
10 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Tecentriq · 4.8 · Hypophysitis“
Suchtreffer
Begriffe & Kennungen
Tecentriq · 4.8 · 90 Hypophysitis
Eintrag öffnenTecentriq · 4.8 · Hypophysitis
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.2% (9/5 039) of patients who received atezolizumab monotherapy. The median time to
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.2% (9/5 039) of patients who received atezolizumab monotherapy. The median time to
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.4% (2/473) of patients who received atezolizumab in combination with nab-paclitaxel
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.4% (2/473) of patients who received atezolizumab in combination with nab-paclitaxel
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.8% (3/393) of patients who received atezolizumab with bevacizumab, paclitaxel, and
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 0.8% (3/393) of patients who received atezolizumab with bevacizumab, paclitaxel, and
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 1.4% (15/1 093) of patients who received atezolizumab in combination with paclitaxel
Eintrag öffnenTecentriq · 4.8 · Hypophysitis occurred in 1.4% (15/1 093) of patients who received atezolizumab in combination with paclitaxel
Eintrag öffnen